Pharma & Biotech News #PharmaBuzz
FDA okays GSK's Exdensur as first biologic, add-on med for severe asthma; issues OAI status to Sun Pharma's India facility
Impressions : 773
Lilly to invest US$ 6 bn in new API plant in Alabama; Biocon buys remaining stake in Biocon Biologics, makes it 100% subsidiary
Impressions : 770
Lilly cuts price of Zepbound; leaked memo on child deaths due to Covid vaccines triggers reaction from former FDA chiefs
Impressions : 1002
Aurobindo Pharma's Generics Cariprazine Receives Approval in US
16 Dec 2025 //
FDA
Ibsa Inst Bio's Vybrique Receives Approval in US
16 Dec 2025 //
FDA
Ascent' Generics Buprenorphine & Naloxone Receives Approval in US
15 Dec 2025 //
FDA
Lib ,'s Biologics Lerochol Receives Approval in US
12 Dec 2025 //
FDA
Entasis Therap's Nuzolvence Receives Approval in US
12 Dec 2025 //
FDA
Milestone Pharma ,'s Cardamyst Receives Approval in US
12 Dec 2025 //
FDA
Amneal's Generics Deflazacort Receives Approval in US
12 Dec 2025 //
FDA
Mylan's Generics Octreotide Acetate Receives Approval in US
12 Dec 2025 //
FDA
Amphastar Pharms' Generics Teriparatide Receives Approval in US
12 Dec 2025 //
FDA
Senores Pharms' Generics Deferiprone Receives Approval in US
11 Dec 2025 //
FDA
Enforcement Report - Week of December 17, 2025
17 Dec 2025 //
FDA
Green Valley Fertility Partners' Receives FDA Warning Letter
16 Dec 2025 //
FDA
Microvascular Tissue's Receives FDA Warning Letter
16 Dec 2025 //
FDA
Sklar Personal Care's Receives FDA Warning Letter
16 Dec 2025 //
FDA
3D Imaging Drug Design's Receives FDA Warning Letter
16 Dec 2025 //
FDA
StuffbyNainax Issues Voluntary Nationwide Recall for Supplement
16 Dec 2025 //
FDA
Enforcement Report - Week of December 10, 2025
10 Dec 2025 //
FDA
MediNatura Issues Voluntary Nationwide Recall of Nasal Spray
10 Dec 2025 //
FDA
CDL Services' Receives FDA Warning Letter
09 Dec 2025 //
FDA
DeVere Manufacturing's Receives FDA Warning Letter
09 Dec 2025 //
FDA
Neurocrine's Movement Disorder Treatment Fails Late-Stage Trial
24 Dec 2025 //
BIOSPACE
J&J vows appeal after US jury hits it with record $1.5B talc
24 Dec 2025 //
REUTERS
Novo Nordisk shares jump after US approves Wegovy pill
24 Dec 2025 //
REUTERS
Pfizer Says Patient Dies After Receiving Hemophilia Drug in Trial
24 Dec 2025 //
REUTERS
Astrazeneca's Ph. 3 Cancer Fail Is Latest Blow To ATR Inhibitors
24 Dec 2025 //
FIERCE BIOTECH
Boehringer Spells Out A $448M Future For Rectify's ABC Program
24 Dec 2025 //
FIERCE BIOTECH
Gilead pays $35M to license pair of HSV assets from Assembly Bio
24 Dec 2025 //
BUSINESSWIRE
Ipsen's ADC push leads to $1B deal for preclinical Simcere drug
24 Dec 2025 //
GLOBENEWSWIRE
Discover Fareva Unterach's expertise in high-tech pre-filled syri
23 Dec 2025 //
PRESS RELEASE
Bharat Biotech, Biofabri In Tech Transfer Deal For TB Vaccine
23 Dec 2025 //
ECONOMICTIMES
Indian Pharma Hails FDA's BA/BE Safety Reporting Stance
22 Dec 2025 //
PHARMABIZ
Samsung Bioepis Launches Ustekinumab Biosimilar In Japan
22 Dec 2025 //
BUSINESSWIRE
Granules India Gets USFDA Tentative Approval For Amphetamine ER
22 Dec 2025 //
PRESS RELEASE
FDA Approves Alembic's Travoprost Ophthalmic Solution USP
22 Dec 2025 //
INDPHARMAPOST
Senores Pharmaceuticals To Acquire Apnar Pharma And Five Andas
17 Dec 2025 //
EXPRESSPHARMA
Cosette Pharma Launches Generic CIPRO HC With (CGT) Exclusivity
16 Dec 2025 //
BUSINESSWIRE
Amphastar Announces FDA Approval For Teriparatide Injection
15 Dec 2025 //
PHARMIWEB
Shilpa Pharma Gets EU Approval For Rotigotine Transdermal Patch
12 Dec 2025 //
INDPHARMAPOST
Senores Pharma Introduces Deferiprone Tablets USP In US
12 Dec 2025 //
EXPRESSPHARMA
Glenmark Pharma USA To Launch Leucovorin Calcium Injection
12 Dec 2025 //
INDPHARMAPOST
Pfizer Says Patient Dies After Receiving Hemophilia Drug in Trial
24 Dec 2025 //
REUTERS
Astrazeneca's Ph. 3 Cancer Fail Is Latest Blow To ATR Inhibitors
24 Dec 2025 //
FIERCE BIOTECH
Boehringer Spells Out A $448M Future For Rectify's ABC Program
24 Dec 2025 //
FIERCE BIOTECH
Gilead pays $35M to license pair of HSV assets from Assembly Bio
24 Dec 2025 //
BUSINESSWIRE
Ipsen's ADC push leads to $1B deal for preclinical Simcere drug
24 Dec 2025 //
GLOBENEWSWIRE
Discover Fareva Unterach's expertise in high-tech pre-filled syri
23 Dec 2025 //
PRESS RELEASE
Bharat Biotech, Biofabri In Tech Transfer Deal For TB Vaccine
23 Dec 2025 //
ECONOMICTIMES
With Biotech Back, Analysts Make Their Picks For 2026
22 Dec 2025 //
BIOSPACE
Applied Biocode Submits Biocode (RPP) With Kingfisher Claim
22 Dec 2025 //
BUSINESSWIRE
Zambon Biotech Initiates Phase 3B ADIP Study For IPX203
22 Dec 2025 //
BUSINESSWIRE
Symbiotec Pharmalab files DRHP with SEBI for IPO
22 Dec 2025 //
BIOSPECTRUMINDIA
CORONA Remedies Commissions Additional Capacity
22 Dec 2025 //
INDPHARMAPOST
Be Patient... Prices Of Your Medicines May Come Down Soon
22 Dec 2025 //
ECONOMICTIMES
Symbiosis Launches Manufacturing in New FDA-Inspected Facility
22 Dec 2025 //
PHARMIWEB
TAPI and Sagimet Biosciences Announce Global License Agreement
19 Dec 2025 //
PRESS RELEASE
Bristol Myers Squibb Enhances U.S. Access To Vital Medicines
19 Dec 2025 //
BUSINESSWIRE
Protheragen Tackles FDA Drug Shortages with GLP-1 API Expansion
19 Dec 2025 //
PHARMIWEB
Inke Acquires Pharmanoid For Ophthalmic High Potent API Assets
18 Dec 2025 //
PRESS RELEASE
Halo Pharma Enhances Manufacturing Capabilities with Macro-Pactor
17 Dec 2025 //
PRESS RELEASE
DGFT Amends Measurement For Key Inputs In Metformin HCL Export
15 Dec 2025 //
PHARMABIZ
TGA Seeks Feedback On Medicine Label Changes In Australia
22 Dec 2025 //
RAPS
Shape Memory Medical Obtains EU MDR Certification For IMPEDE
22 Dec 2025 //
BUSINESSWIRE
FDA Posts Warning Letters To Manufacturers Of Breast Binders
19 Dec 2025 //
RAPS
Minnesota Jury Awards $65.5M vs. Johnson & Johnson
19 Dec 2025 //
BUSINESSWIRE
BMS' Cobenfy TV Ad Is Latest Target Of FDA Untitled Letter Spree
19 Dec 2025 //
FIERCE PHARMA
AZ To Pull Bleeding Reversal Agent After FDA Flags Risk Imbalance
19 Dec 2025 //
FIERCE PHARMA
FDA hit Catalent's Maryland Manufacturing Sites with Form 483
19 Dec 2025 //
FIERCE PHARMA
AKCDA Urges DCGI Action On Kerala Discount Pharmacies' Fake Drug
17 Dec 2025 //
PHARMABIZ
Novo Gets Warning Letter At Site Formerly Owned By Catalent
17 Dec 2025 //
FIERCE PHARMA
Trial By Fire: Over 60% Of Pharma SMEs May Be Forced To Shut Shop
16 Dec 2025 //
ECONOMICTIMES
Ayush Ministry Urged To Boost Single Window Clinical Trial
22 Dec 2025 //
PHARMABIZ
Colorectal Cancer Awareness Campaign Drives Diagnosis In Nigeria
22 Dec 2025 //
FIERCE PHARMA
New Guide: Gateway to Innovative Perioperative Nursing Mindset
22 Dec 2025 //
PHARMIWEB
TraceLink Wins 3rd 2025 Merit Award in Healthcare Innovation
22 Dec 2025 //
PR NEWSWIRE
FDA Approves RevBio's Bone Glue for Regenerative Trials
22 Dec 2025 //
BUSINESSWIRE
Quanterix Study Redefines Alzheimer's Neuropathology Prevalence
22 Dec 2025 //
BUSINESSWIRE
Hologic Breast Cancer Study Bolsters Use Of Mammogram AI
22 Dec 2025 //
FIERCE BIOTECH
InSilicoTrials, Jackson Lab Lead $30M ARPA-H Project
22 Dec 2025 //
BUSINESSWIRE
Chonnam Scientists Convert Formaldehyde into Methanol
22 Dec 2025 //
PR NEWSWIRE BIO
Abbott's Volt pulsed field ablation system scores FDA approval
22 Dec 2025 //
PR NEWSWIRE
Savara Resubmits BLA for Molbreevi to Treat Autoimmune PAP
22 Dec 2025 //
BUSINESSWIRE
PTC Therapeutics Gets Japan Approval For Sephience In (PKU)
22 Dec 2025 //
PR NEWSWIRE BIO
FDA Approves JASCAYD Tablets For Progressive Pulmonary Fibrosis
22 Dec 2025 //
PR NEWSWIRE
Ipsen Fails to Land Pivotal Rare Disease Trial
20 Dec 2025 //
FIERCE BIOTECH
Kyowa Kirin Poised For Windfall With Newborn Screening Update
19 Dec 2025 //
BIOSPACE
FDA Approves Cytokinetics' MYQORZO for Symptomatic Obstructive
19 Dec 2025 //
GLOBENEWSWIRE
FDA Approves JASCAYD Tablets For Progressive Pulmonary Fibrosis
19 Dec 2025 //
GLOBENEWSWIRE
Mandos, Subsidiary Of Beren, Submits Adrabetadex NDA
19 Dec 2025 //
PHARMIWEB
US FDA Approves Cytokinetics' Heart Disease Drug
19 Dec 2025 //
PRESS RELEASE
Biomarin to Buy Amicus for $4.8 B in Rare Disease Bet
19 Dec 2025 //
PRESS RELEASE
Neurocrine's Movement Disorder Treatment Fails Late-Stage Trial
24 Dec 2025 //
BIOSPACE
J&J vows appeal after US jury hits it with record $1.5B talc
24 Dec 2025 //
REUTERS
Novo Nordisk shares jump after US approves Wegovy pill
24 Dec 2025 //
REUTERS
CORONA Remedies Commissions Additional Capacity
23 Dec 2025 //
INDPHARMAPOST
Cipla Launches Inhalable Insulin For Diabetes Care
23 Dec 2025 //
ECONOMICTIMES
China's NMPA Approves Abbisko's Pimicotinib
23 Dec 2025 //
GLOBENEWSWIRE
FDA Approves Novo Nordisk's Wegovy Pill For Adult Weight Loss
23 Dec 2025 //
PR NEWSWIRE
Trump Launches Federally Regulated Healthcare Sector
22 Dec 2025 //
PHARMIWEB
Top 10 Fierce Pharma Marketing Stories of 2025: Recap
22 Dec 2025 //
FIERCE PHARMA
CMMI Proposes New Models To Lower Drug Prices In Parts B, D
22 Dec 2025 //
FIERCE PHARMA

Market Place
Sourcing Support